Nurx is a healthcare technology offering primary care solutions including birth control, HPV testing, PrEP for HIV prevention, and STI testing and treatment.
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 8/11/2020 | Series C-1 | $317.71MM | $XXX.XX | $XXX.XX |
| 8/15/2019 | Series C | $291.17MM | $XXX.XX | $XXX.XX |
| 7/11/2018 | Series B-1 and B-2 | $113.57MM | $XXX.XX | $XXX.XX |
| 11/3/2016 | Series A-1, A-2, A-3, and A-4 | $20.77MM | $XXX.XX | $XXX.XX |
